COVID-19 Study of Safety and Tolerability of Alvelestat

NCT04539795 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Alvelestat
DRUG: Placebo

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]